In addition, in a diet-induced obesity mouse model, the FXR/TGR5 dual agonist suppresses diet-induced kidney disease by changing the composition of kidney bile acids, reducing their accumulation, and decreasing triglyceride and ceramide levels in the kidney. This evidence concerns the gene NR1H4 and kidney disorder.